Subacute combined degeneration of the spinal cord: Manifestations of oesophageal epidermoid carcinoma;Degeneracion combinada subaguda espinal: Manifestacion de un carcinoma epidermoide esofagico

Revista de Neurologia

Volumn 25, Issue 143, 1997, Pages 1098-1101

  Madrid, A ^a   Casado, J L ^b   Perezazquin F ^a   Vazquez A ^a   Garzon F ^a   Gil Peralta, A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

Author keywords

Cancer; Megaloblastic anemia; Pernicious anemia; Subacute combined degeneration of the spinal cord; Vitamin B12 deficiency

Indexed keywords

AUTOANTIBODY; CYANOCOBALAMIN; INTRINSIC FACTOR;

AGED; ARTICLE; CASE REPORT; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MALABSORPTION; MEGALOBLASTIC ANEMIA; PARANEOPLASTIC SYNDROME; SCHILLING TEST; SPINAL CORD ATROPHY; SQUAMOUS CELL CARCINOMA; ESOPHAGUS; ESOPHAGUS TUMOR; FATALITY; PATHOLOGY; PERNICIOUS ANEMIA; SPINAL CORD DISEASE; ULTRASTRUCTURE;

AGED; ANEMIA, MEGALOBLASTIC; ANEMIA, PERNICIOUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FATAL OUTCOME; HUMANS; SPINAL CORD DISEASES;

EID: 0031182006     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Babior BM, Bunn HF. Anemias megaloblásticas. In Wilson JD, Braunwald E, Isselbacher KJ, et al, ed. Tratado de Medicina Interna. 12 ed. Madrid: McGrawHill; 1991. p. 1766-73.
2. Beck WS. Anemias megaloblásticas. In Wyngaarden JB, Smith LIH. Tratado de Medicina Interna. 17 ed. Madrid: Interamericana; 1986. p. 993-1000.
3. Healton EB, Savage DG, Brust JCM, et al. Neurologic aspects of cobalamin deficiency. Medicine 1991; 70: 229-45.
4. Hsing AW, Hanson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993; 71: 745-50.
5. Brinton LA, Gridley G, Hrubec Z, et al. Cancer risk following pernicious anemia. Br J Cancer 1989; 59: 810-3.
6. Festen HP. Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract. Scand J Gastroenterol 1991; 26: 1-7.
7. Addison T. On the constitutional and local effects of disease of the supra-renal capsules. London: Samuel Highley; 1855.
8. Cooper BA, Whitehead VM. Evidence that some patiens with pernicious anemia are not recognized by radiodilution assay for cobalamin in serum. N Engl J Med 1978; 299: 816-8.
9. Kolhourse JF, Kondo H, Allen NC, et al. Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin. N Engl J Med 1978; 299: 785-92.
10. Herbert V. Biology of disease. Megaloblastic anemias. Lab Invest 1985; 52: 3-19.
11. Carmel R, Herbert V. Intrinsic factor antibody in the saliva of a patient with pernicious anemia. Lancet 1967; 1: 80.
12. Chanarin I. The megaloblastic anaemias. Oxford: Blackwell Scientific Publications; 1969. p. 316-31.
13. Davidson RJ, Atrah HI, Sewell HF. Longitudinal study of circulating gastric antibodies in pernicious anaemia. J Clin Pathol 1989; 42: 1092-5.
14. Junca J, Cuxart A, Olive A, Tural C. Anti-intrinsic factor antibodies in systemic lupus erythematosus. Lupus 1993; 2: 111-4.
15. Davis RE, McCann VJ, Stanton KG. Type I diabetes and latent pernicious anemia. Med J Aust 1992; 156: 160-2.
16. Kuwano H, Baba H, Matsuda H. Hypercalcemia related to the poor prognosis of patients with squamous cell carcinoma of the esophagus. J Surg Oncol 1989; 42: 229-33.
17. 2 produced by the tumor cell. Gan No Rinsho 1990; 36: 2445-9.
18. Collantes E, Cisnal A, González J. Polyarthritis, vasculitis and cancer of the esophagus: a propos of a new case. Rev Rhum Mal Osteoartic 1989; 56: 425.
19. Frank M, Moses MC. Squamous cell carcinoma of the esophagus. Natural history, incidence, etiology and complications. Gastroenterol Clin North Am 1991; 20: 703-10.
20. Herrero M, Sánchez-Guilarte J, Manzarbeitia F, et al. Anemia macrocítica y disfagia. Rev Clin Esp 1994; 194: 649-50.